Correlation Between Korea Information and Sk Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Korea Information and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korea Information and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Korea Information Communications and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on Korea Information and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korea Information with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korea Information and Sk Biopharmaceutica.

Diversification Opportunities for Korea Information and Sk Biopharmaceutica

0.25

Correlation Coefficient

Korea Information  Sk Biopharmaceutica

Modest diversification

The 3 months correlation between Korea and 326030 is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Korea Information Communicatio and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and Korea Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korea Information Communications are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of Korea Information i.e., Korea Information and Sk Biopharmaceutica go up and down completely randomly.

Pair Corralation between Korea Information and Sk Biopharmaceutica

Assuming the 90 days trading horizon Korea Information Communications is expected to under-perform the Sk Biopharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, Korea Information Communications is 1.69 times less risky than Sk Biopharmaceutica. The stock trades about -0.11 of its potential returns per unit of risk. The Sk Biopharmaceuticals Co is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  10,090,000  in Sk Biopharmaceuticals Co on September 26, 2024 and sell it today you would earn a total of  360,000  from holding Sk Biopharmaceuticals Co or generate 3.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.65%
Values	Daily Returns

Korea Information Communicatio  vs.  Sk Biopharmaceuticals Co

Korea Information

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Korea Information Communications has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Sk Biopharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sk Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Korea Information and Sk Biopharmaceutica

The main advantage of trading using opposite Korea Information and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korea Information position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.

The idea behind Korea Information Communications and Sk Biopharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.